Bruxism, or involuntary teeth grinding, can occur during the day or at night and have significant consequences: muscle pain, tooth wear, headaches, sleep disorders, and hypertrophy of the masseter muscles. At the Main d'Or medical-aesthetic clinic, we offer an effective, non-surgical, and safe solution: neuromodulator injections (such as Botox®).
These injections specifically target the masseter muscles responsible for excessive tension. By temporarily relaxing these muscles, episodes of nighttime grinding are significantly reduced while relieving associated tension. The treatment is quick, virtually painless, and does not require any downtime. Results are generally noticeable within 7 to 10 days after the session, with effectiveness lasting between 4 and 6 months.
.png)
.png)
Chronic teeth grinding can alter the appearance of the lower face. Hypertrophy of the masseter muscles often gives the jaw a square appearance, which is particularly noticeable in women. At the Main d'Or medical aesthetics clinic, the neuromodulators used to treat bruxism also offer a significant aesthetic benefit.
By relaxing overworked muscles, the lower part of the face gradually regains a softer, more harmonious appearance without affecting chewing. This dual benefit—functional relief and refined contours—makes this treatment a preferred option for people affected by bruxism. A personalized assessment with a professional allows doses to be adjusted and ensures a natural result tailored to your facial physiology.
Jaw tension should not be taken lightly. Thanks to a targeted and proven approach, Main d’Or Medical Aesthetic Clinic offers effective, safe bruxism treatment tailored to your needs. Make an appointment for a personalized assessment and discover how neuromodulator injections can improve both your comfort and the appearance of your face.
In the emergence of non-surgical aesthetic care, the Main d'Or clinic was founded by Mirna Saadé - a nurse clinician, with a mission to offer injectable aesthetic care and skin care where safety and efficacy are the priorities.